Clinical trial
Rofecoxib and Bupivacaine to Prevent Pain After Third Molar (Wisdom Tooth)…
NCT00050362 · National Institute of Dental and Craniofacial Research (NIDCR), NIH · Completed
Key facts
| NCT number | NCT00050362 |
|---|---|
| Title | Rofecoxib and Bupivacaine to Prevent Pain After Third Molar (Wisdom Tooth) Extraction |
| Official title | Evaluation of a Long-Acting Local Anesthesia (Bupivacaine) and a Selective COX-2 Inhibitor (Rofecoxib) in Suppression of Central Sensitization |
| Lead sponsor | National Institute of Dental and Craniofacial Research (NIDCR), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pain, Tooth Extraction |
| Intervention type | Drug |
| Interventions | Rofecoxib and Bupivacaine |
| Enrollment | 136 |
| Start date | Dec 1, 2002 |
| Completion | Oct 1, 2004 |
| First posted | Dec 5, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: